Senescence‐associated secretory phenotype (SASP) index in individuals across the Alzheimer’s disease continuum
Alzheimer's & Dementia · 2024-12 · 20 (S2)
DOI: 10.1002/alz.092727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 09.01.2025. Verfasst von Alvaro de Oliveira Franco und 5 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Cellular senescence (CS) is a hallmark of aging. Senescence‐associated secretory phenotype (SASP) index was recently developed based on the levels of blood SASP‐related proteins. Although aging is a primary risk factor for Alzheimer's disease (AD), the role of CS in this neurodegenerative condition is not well understood. Here, we investigated the association of the SASP index (SI) with classical markers of AD.
Methods
We assessed 593 participants (60 cognitively unimpaired [CU], 412 with mild cognitive impairment [MCI], and 121 with AD dementia), from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort (Table 1). SI was derived through a weighted sum of the standardized concentrations of 12 available SASP proteins, each weighted according to the eigenvectors from a Principal Component Analysis of these proteins (Table 2). Associations were tested using generalized linear models adjusted for age, sex, education, and APOE ε4 status. Statistical analyses were performed in the R environment, significance set at p < 0.05, and multiple comparisons correction was performed using the false discovery rate.
Results
Regression analysis demonstrated that CU individuals showed lower SI values than MCI (p = 0.044) and AD dementia (p = 0.039) individuals. We found that the SI was positively associated with age (p < 0.001), cerebrospinal fluid (CSF) neurofilament light (NfL) (β = 94.838, p = 0.007), plasma NfL (β = 4.08, p‐value < 0.001) and Clinical Dementia Rating sum of the boxes (β = 0.12, p = 0.004). On the other hand, the SI was negatively associated with the middle temporal gyrus volume (β = ‐208.81, p = 0.013), with a negative trend with hippocampus volume (β = ‐56.15, p = 0.053). Additionally, the SI showed no significant correlation with CSF Aβ42, CSF t‐tau and p‐tau181, CSF GFAP, education level, and the whole brain, entorhinal gyrus, fusiform, and entorhinal cortices volumes.
Conclusions
Here, we showed that the SI closely associates with hallmark features of AD, such as age, cognition, fluid, and imaging biomarkers. Our results help to better understand the role of aging in AD and suggest that the SI can be used as a proxy for CS in AD.
Zitieren
APA
Franco, A. D. O., Schlickmann, T. H., Ferrari‐Souza, J. P., Bastiani, M. A. D., Castilhos, R. M., & Zimmer, E. R. (2024). Senescence‐associated secretory phenotype (SASP) index in individuals across the Alzheimer’s disease continuum. Alzheimer's & Dementia, 20(S2). https://doi.org/10.1002/alz.092727
Vancouver
Franco ADO, Schlickmann TH, Ferrari‐Souza JP, Bastiani MAD, Castilhos RM, Zimmer ER. Senescence‐associated secretory phenotype (SASP) index in individuals across the Alzheimer’s disease continuum. Alzheimer's & Dementia. 2024;20(S2). doi:10.1002/alz.092727
BibTeX
@article{Franco2024,
author = {Franco, Alvaro de Oliveira and Schlickmann, Thomas Hugentobler and Ferrari‐Souza, João Pedro and Bastiani, Marco Antônio de and Castilhos, Raphael Machado and Zimmer, Eduardo R.},
title = {Senescence‐associated secretory phenotype (SASP) index in individuals across the Alzheimer’s disease continuum},
journal = {Alzheimer's & Dementia},
year = {2024},
volume = {20},
number = {S2},
doi = {10.1002/alz.092727}
}
EUVIMED